RGNT

REGENTIS BIOMATERIALS LTD. RGNT

NYSESmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$2.98M total
Rosalind Advisors, Inc.
$2.48M+179.0%
Warberg Asset Management LLC
$306.2KNew
JANE STREET GROUP, LLC
$153.0KNew
RENAISSANCE TECHNOLOGIES LLC
$47.1KNew
UBS Group AG
$1.5K+29.9%
Tower Research Capital LLC (TRC)
$39New
See all 6 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

FY 2025
EDGAR

EPS (Diluted)

FY 2025
EDGAR

Debt/Equity

FY 2025
EDGAR

Loading ratio trend…

RGNT insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About REGENTIS BIOMATERIALS LTD. (RGNT): stock profile, AI score and financials

REGENTIS BIOMATERIALS LTD. (RGNT) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. RGNT is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Top institutional holders of RGNT by reported 13-F value include Rosalind Advisors, Warberg Asset Management, JANE STREET GROUP, based on the most recent SEC filings. RGNT trades on the NYSE exchange and files with the SEC under CIK 1912966. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate RGNT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for REGENTIS BIOMATERIALS LTD. directly from SEC EDGAR.

SEC EDGAR: CIK 1912966 →